Eli Lilly and Co

Return on Assets, %

9.3

-2.7

Net income margin, %

23.4

2.8

EBITDA margin, %

37

10.8

Debt to Equity, %

234.1

19.2

Intangible assets and goodwill, %

18.5

3.6

Revenue CAGR 3Y, %

11.6

8.5

Total Equity change 1Y, %

1.1

0

Revenue Y, % chg

19.5

0.5

P/E

129.5

22.7

P/BV

66.2

1.5

P/S

20.9

2.3

EV/S

21.5

2.4

EV/EBITDA

62.1

7.4

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

11.4

51.3

Forward P/E

53.4

15.6

Dividend Yield, %

0.6

1.7

Forward Dividend Yield, %

0.7

0.2

Expected dividend per share

5.4

0

Payout Ratio, %

80.5

30.3

Dividend Ex Date

2024-02-14